Related Experiment Video
Updated: Aug 13, 2025

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina
Published on: May 6, 2015
P2X7 Is Involved in the Mouse Retinal Degeneration via the Coordinated Actions in Different Retinal Cell Types
Ponarulselvam Sekar1,2, George Hsiao3, Yuan-Shen Chen4
1Graduate Institute of Medical Sciences, Taipei Medical University, Taipei 110301, Taiwan.
Abstract:
Adenosine triphosphate (ATP) released from dying cells with high concentrations is sensed as a danger signal by the P2X7 receptor. Sodium iodate (NaIO3) is an oxidative toxic agent, and its retinal toxicity has been used as the model of dry age-related macular degeneration (AMD). In this study, we used NaIO3-treated mice and cultured retinal cells, including BV-2 microglia, 661W photoreceptors, rMC1 Müller cells and ARPE-19 retinal epithelial cells, to understand the pathological action of P2X7 in retinal degeneration. We found that NaIO3 can significantly decrease the photoreceptor function by reducing a-wave and b-wave amplitudes in electroretinogram (ERG) analysis. Optical coherence tomography (OCT) analysis revealed the degeneration of retinal epithelium and ganglion cell layers. Interestingly, P2X7-/- mice were protected from the NaIO3-induced retinopathy and inflammatory NLRP3, IL-1β and IL-6 gene expression in the retina. Hematoxylin and eosin staining indicated that the retinal epithelium was less deteriorated in P2X7-/- mice compared to the WT group. Although P2X7 was barely detected in 661W, rMC1 and ARPE-19 cells, its gene and protein levels can be increased after NaIO3 treatment, leading to a synergistic cytotoxicity of BzATP [2'(3')-O-(4-benzoylbenzoyl)adenosine-5'-triphosphate tri(triethyleneammonium)salt] and NaIO3 administration in ARPE-19 cells. In conclusion, the paracrine action of the ATP/P2X7 axis via cell-cell communication is involved in NaIO3-induced retinal injury. Our results show that P2X7 antagonist might be a potential therapy in inflammation-related retinal degeneration.
Insights
High concentrations of adenosine triphosphate (ATP) signal danger via the P2X7 receptor. Blocking P2X7 protects against sodium iodate-induced retinal degeneration, suggesting P2X7 antagonists as a potential therapy for inflammatory eye diseases.
Area of Science:
- Ophthalmology
- Neuroscience
- Immunology
Background:
- Dying cells release adenosine triphosphate (ATP), acting as a danger signal sensed by the P2X7 receptor.
- Sodium iodate (NaIO3) induces oxidative retinal toxicity, serving as a model for dry age-related macular degeneration (AMD).
Purpose of the Study:
- To investigate the role of the P2X7 receptor in sodium iodate-induced retinal degeneration.
- To evaluate the therapeutic potential of targeting the P2X7 pathway in retinal injury.
Main Methods:
- Utilized sodium iodate (NaIO3)-treated mice and cultured retinal cells (microglia, photoreceptors, Müller cells, retinal epithelial cells).
- Assessed retinal function using electroretinogram (ERG) and retinal structure with optical coherence tomography (OCT).
- Analyzed gene expression of inflammatory markers (NLRP3, IL-1β, IL-6) and P2X7 levels.
Main Results:
- NaIO3 treatment significantly impaired photoreceptor function and caused retinal degeneration in wild-type mice.
- P2X7 knockout mice exhibited protection against NaIO3-induced retinopathy and reduced retinal inflammation.
- NaIO3 upregulated P2X7 expression in retinal cells, enhancing cytotoxicity when combined with BzATP.
Conclusions:
- The ATP/P2X7 axis, through paracrine signaling and cell-cell communication, contributes to sodium iodate-induced retinal injury.
- P2X7 receptor antagonists represent a promising therapeutic strategy for inflammation-related retinal degeneration.

